Endo International Plc
(NASDAQ : ENDP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.53%18.8714.1%$236.63m
SHPGShire PLC Sponsored ADR
-0.75%125.720.4%$194.43m
SAGESAGE Therapeutics, Inc.
4.04%169.789.8%$118.20m
PRGOPerrigo Co. Plc
1.22%88.106.6%$82.81m
ICPTIntercept Pharmaceuticals, Inc.
-1.65%59.7822.0%$69.88m
MDCOMedicines Company
2.58%33.6522.1%$64.51m
JAZZJazz Pharmaceuticals Plc
1.33%146.702.2%$57.24m
MNKMallinckrodt Plc
-0.36%16.6518.5%$52.82m
CTLTCatalent Inc
2.99%43.752.6%$51.88m
GWPHGW Pharmaceuticals PLC Sponsored ADR
3.06%134.847.6%$51.39m
UTHRUnited Therapeutics Corporation
-7.52%124.8114.5%$48.56m
ICLRICON Plc
-0.53%114.454.1%$43.64m
PBHPrestige Brands Holdings, Inc.
0.12%34.913.8%$41.45m
CORTCorcept Therapeutics Incorporated.
4.76%16.085.5%$40.69m
PTLAPortola Pharmaceuticals, Inc.
-5.73%45.467.8%$38.12m

Company Profile

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The company operates through the following segments: U.S. Branded Pharmaceuticals, U.S. Generic pharmaceuticals and International Pharmaceuticals. The U.S. Branded Pharmaceuticals offers products that focus on the treatment and management of conditions in urology, urologic oncology, endocrinology, and orthopedics. The U.S. Generic pharmaceuticals segment consist of a differentiated product portfolio including high-barrier-to-entry products, first-to-file or first-to-market opportunities that are difficult to formulate, difficult to manufacture or face complex legal and regulatory challenges. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. Endo International was founded on October 31, 2013 and is headquartered Dublin, Ireland.